KPIs & Operating Metrics(New)

Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Current Assets Current Taxes Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Liabilities from Discontinued Operations Long-Term Deferred Tax Long-Term Investments Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Other Non-Current Assets Other Non-Current Liabilities Payables Pension Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares

Cash Flow Statement

Daily Values

Growth Metrics

Organon (OGN) Other Accumulated Expenses (2023)

Organon has reported Other Accumulated Expenses over the past 1 years, most recently at $1.0 million for Q4 2023.

For Q4 2023, Other Accumulated Expenses changed N/A year-over-year to $1.0 million; the TTM value through Dec 2023 reached $1.0 million, changed N/A, while the annual FY2023 figure was $1.0 million, N/A changed from the prior year.
Other Accumulated Expenses for Q4 2023 was $1.0 million at Organon.
Over five years, Other Accumulated Expenses peaked at $1.0 million in Q4 2023 and troughed at $1.0 million in Q4 2023.